The industry of healthcare in Finland is growing more
effectively in the recent with the introduction of new technologies and
significant contribution of government by making aware from the dangerous
diseases through facilitating the numerous programs to the general public of
the region. The healthcare sector in Finland contains a highly decentralized
three-level publicly funded healthcare system and much smaller part of private
segment. Whereas, the Ministry of Social Affairs and Health has the very huge in
decision-making, regulatory and the local government are held responsible for
serving healthcare to their inhabitants. Moreover, the report identifies the
key trends in the healthcare market and serves the insights into regulatory,
reimbursement landscape and demographic with the healthcare infrastructure of
Finland. Furthermore, the key players of this industry in Finland is doing
effective job for dominating the market with the handsome amount of share and
establishing significant research and development programs which results the
actual growth to the market in the coming trend.
Finland is one of the rapidly emerging markets in the
EU which focused majorly on the pharmaceuticals research and development.
According to the report analysis, ‘CountryFocus:
Healthcare, Regulatory and Reimbursement Landscape - Finland’ states
that Finland spends approximately 9.4% of its GDP on the healthcare sector for
making it more effective and beneficial for both the key player and the
patients. The value of pharmaceuticals market dropped from USD 2.5 billion in
2010 to USD 2.5 billion in 2015 at negative CAGR of 0.3% due to an increase in
generic volume from 34.0% in 2010 to 42.0% in 2015. Moreover, the Finland
offers its populaces a universal healthcare. The anticipation of disease and
other types of health promotion have been the main aim of Finnish healthcare
strategic policies for so long over the decades, which have resulted in the
obliteration of certain communicable diseases and significant development in
the health of inhabitants. However, the Finnish healthcare can be considered a
success due to the several pointers.
The government of this region decides on primary
national policies and strategies with the priorities and proposes bills to be
discussed by the parliament. Whereas, the primary care is obtained from the
healthcare centers retaining general practitioners and nurses that serve most
day-to-day medical services and healthcare centers also active and prominent in
the promotion of health related activities. Moreover, it is anticipated that
the market will increase to USD of 2.7 billion in the recent years. Meanwhile,
in 2010, the market value in terms of Euros was EUR 1.9 billion and from 2015
grew at a CAGR of 3.0%. It is expected that in 2022 it will reach to EUR 2.8
billion. In 2010, the Finnish medical devices market was worth at USD 0.9
billion, which grew to USD 1.3 billion in 2017.
The major segments were cardiovascular devices,
diabetes care devise, in vitro diagnostics, ophthalmic devices and orthopedic
devices. The growing aging population, promising foreign investment
surroundings and exclusive innovations are anticipated to operate the growth of
the pharmaceuticals market. Therefore, in the coming trend it is expected that
the healthcare market in Finland will grow more significantly over the decades
with the increased healthcare expenditure and the existence of counterfeit medicines.
For more information on the research
report, refer to below link: -
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249